Novartis logo
Novartis
NVSEF | OTC
Chart Builder DCF Calculator
$134.20
-$6.73 (-4.78%)
At close: Oct 2, 2026, 3:14 PM ET

Novartis Income Statement

Income statement explained
Fiscal Year
Period Ending
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
FY 2020
Dec 31, 2020
FY 2019
Dec 31, 2019
51.72B 46.66B 51.83B 52.88B 49.9B 48.68B
12.83B 12.02B 15.49B 15.87B 15.12B 14.43B
38.9B 34.64B 36.34B 37.01B 34.78B 34.25B
14.54B 9.77B 9.2B 11.69B 10.15B 9.09B
550.78M 436M 389.37M 71.15M 91M 251.43M
13.64B 9.12B 8.37B 26.14B 9.88B 8.94B
11.94B 14.85B 6.96B 24.02B 8.07B 11.73B
12.57B 12.49B 14.25B 14.89B 14.2B 14.37B
10.02B 11.37B 10B 9.54B 8.98B 9.4B
1.76B 1.01B -101.22M 269.57M 110.43M 305.83M
24.35B 24.87B 27.15B 25.32B 24.63B 25.17B
1.01B 855M 860.33M 906.93M 869M 925.69M
– – – – – –
37.18B 36.89B 42.63B 41.19B 39.75B 39.59B
1.7B 551M 1.42B 2.12B 1.81B 1.79B
2.02B 2.08B 2.18B 2.24B 2.28B 2.29B
2.04B 2.09B 2.2B 2.26B 2.3B 2.32B
5.92 7.63 3.29 10.73 3.76 3.15
5.87 7.58 3.27 10.65 3.73 3.12
20.72B 19.52B 15.21B 17.17B 16.18B 15.62B
14.65B 10.68B 8.28B 11.73B 10.15B 9.09B
6.07B 8.83B 6.92B 5.44B 5.43B 5.98B

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.